Khoo et al 2021 (resonance) ¿ ¿single-centre experience with three metallic ureteric stents (allium® urs, memokath¿-051 and resonance®) for chronic ureteric obstruction¿.Operating theatre records were reviewed to identify patients who had undergone metallic ureteric stent insertion with either allium® urs, memokath¿-051 or resonance® for cuo.Post-operatively, all patients were reviewed in clinic with serum creatinine, abdominal x-ray, and mercaptoacetyltriglycine-3 (mag-3) renogram at 6 weeks, and reviewed again with serum creatinine and abdominal x-ray at 3 months and then every 6 months.If there was clinical concern of stent failure, ct urogram (if estimated glomerular filtration rate (egfr) =30ml/min/1.73m2) or urinary tract ultrasound (if egfr <30ml/min/1.73m2) was performed.At each follow-up appointment, patient-reported stent symptoms (including irritative voiding symptoms, pain, and haematuria) were noted.Resonance: 29 patients, 58 sies) off-label use: resonance stents used in ureters with intrinsic causes of compression.As per table 4: 12 devices (5 patients) were used for iatrogenic + other aetiologies.Adverse effects captured under separate complaints.
|
Device evaluation: the resonance stent set devices of unknown lot # were not available for evaluation, therefore a document based investigation will be carried out.As the lot # of the resonance stent set device is unknown it is not possible to carry out a review of the manufacturing records.However, prior to distribution all resonance stent set devices are subjected to a visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.As per instructions for use (ifu0020-8): ¿used for temporary stenting of the ureter in adult patients with extrinsic ureteral obstruction.Intended for one time use.¿ there is evidence to suggest the user did not follow the instructions for use which accompany this device.Root cause review: a definitive root cause can be attributed to off label use.When the device is used outside of its validated state it is not possible to definitively state how the device will perform.The use of the resonance stents in ureters with intrinsic causes of compression is outside of the intended use set out in the ifu.Summary: complaint is confirmed as the failure was verified in the laboratory.According to the initial report, the patients suffered no adverse events as a result of this occurrence.Complaints of this nature will continue to be monitored for emerging trends.
|